CM
CYTK icon

Caption Management’s Cytokinetics CYTK Stock Holding History

Caption Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-245,000
Closed -$17.6M – 1746
2026
Q1 		$16.1M Buy
245,000
+217,001
+775% +$13.8M 0.09% 232
2025
Q4 		$1.78M Sell
27,999
-2,358
-8% -$147K 0.01% 875
2025
Q3 		$1.67M Buy
30,357
+11,357
+60% +$468K 0.01% 918
2025
Q2 		$628K Sell
19,000
-39,739
-68% -$1.38M 0.01% 1058
2025
Q1 		$2.36M Buy
58,739
+3,909
+7% +$180K 0.02% 634
2024
Q4 		$2.58M Buy
54,830
+21,330
+64% +$1.11M 0.02% 610
2024
Q3 		$1.77M Sell
33,500
-33,500
-50% -$1.87M 0.03% 604
2024
Q2 		$3.63M Sell
67,000
-198,554
-75% -$12M 0.06% 345
2024
Q1 		$18.6M Sell
265,554
-154,805
-37% -$12M 0.28% 77
2023
Q4 		$35.1M Buy
420,359
+405,284
+2,688% +$14.7M 0.47% 35
2023
Q3 		$444K Buy
+15,075
New +$502K 0.01% 959
2023
Q1 		– Sell
-100,354
Closed -$4.6M – 1183
2022
Q4 		$4.6M Buy
+100,354
New +$4.32M 0.07% 321
2020
Q3 		– Sell
-61,600
Closed -$1.44M – 1066
2020
Q2 		$1.45M Buy
61,600
+19,864
+48% +$372K 0.05% 446
2020
Q1 		$492K Buy
+41,736
New +$532K 0.03% 547
2019
Q4 		– Sell
-14,400
Closed -$164K – 861
2019
Q3 		$164K Sell
14,400
-15,600
-52% -$196K 0.01% 604
2019
Q2 		$337K Buy
+30,000
New +$289K 0.02% 521

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caption Management's CYTK Position: Q2 2026 in Review

Caption Management sold out of Cytokinetics (CYTK) in Q2 2026, closing a stake of 245,000 shares — an estimated $17.6M sold.

Caption Management first reported a position in CYTK in Q2 2019 and held it in 16 quarters. The position peaked at $35.1M in Q4 2023. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Caption Management reported no remaining Cytokinetics position as of Q2 2026 after selling out during the quarter.
  • Caption Management sold 245,000 Cytokinetics shares in Q2 2026, an estimated $17.6M.
  • Caption Management first reported a position in Cytokinetics in Q2 2019 and held it in 16 quarters.
  • Caption Management's Cytokinetics position peaked at $35.1M in Q4 2023.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.